Addiction Science & Clinical Practice

Article	Citations
Is it about substituting an addiction with another? development and initial psychometric properties of the first heated tobacco products addiction questionnaire (HeaTPAQ)	77
Examining outcomes for service users accessing the Breaking Free Online computer-assisted therapy program for substance use disorders via a ‘telehealth’ approach: protocol for a two arm, parallel grou	53
Improving alcohol and substance use screening in school-age children: translation, adaptation and psychometric evaluation of the CRAFFT tool for Lumasaaba, Uganda	47
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use	38
Patient perceptions of the use of e-cigarettes in smoking treatment programs: a qualitative analysis	35
Buprenorphine misinformation and willingness to treat patients with opioid use disorder among primary care-aligned health care professionals	31
Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series	31
Advancing pre-exposure prophylaxis (PrEP) implementation for people who use drugs: an introduction to and lessons from the special series	27
Virtual reality cue exposure as an add-on to smoking cessation group therapy: a randomized controlled trial	26
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process	26
Tobacco cessation among smokers under substance use treatment for alcohol and/or cannabis: study protocol and pilot study	24
Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study	21
Virtual reality interventions in the assessment and treatment of alcohol use disorder - a systematic scoping review on methodology	19
Problematic substance use among patients in a Swedish outpatient psychiatry setting: staff and manager perceptions of digital options for increased intervention access	19
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use	19
Correction: Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	18
Timing of hepatitis C treatment initiation and retention in office-based opioid treatment with buprenorphine: a retrospective cohort study	18
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder	17
Cost of implementing evidence-based practices to reduce opioid overdose fatalities in New York State communities	17
The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State	16
Patient evaluation of a smartphone application for telehealth care of opioid use disorder	16
Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial	15
Spatial accessibility of substance use disorder treatment programs, compared with other health care facilities, in New York State, 2024	15
Correction: Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	15
mHealth Incentivized Adherence Plus Patient Navigation (MIAPP): protocol for a pilot randomized controlled trial to improve linkage and retention on buprenorphine for hospitalized patients with metham	14

Adapting the Grog survey app for alcohol screening and feedback in aboriginal and Torres Strait Islander health services: a mixed methods study protocol	13
Proceedings of the 18th Annual Conference of INEBRIA	13
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study	12
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation	12
“Take services to the people”: strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda	12
Efficacy of the GLP-1 receptor agonist, semaglutide, in abstinence from illicit and nonprescribed opioids in an outpatient population with OUD: a randomized, double-blind, placebo-controlled clinical	12
What smartphone apps exist to support recovery from opioid use disorder? A content analysis of publicly available opioid-related smartphone apps	12
Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods	12
“There’s always somebody that you can identify with”: a qualitative study of patient perspectives on buprenorphine group medical visits	12
Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder	11
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches	11
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study	11
Buprenorphine and postpartum contraception utilization among people with opioid use disorder: a multi-state analysis	11
A stakeholder-driven approach to designing a peer recovery coach role for implementation in community-oriented primary care teams in South Africa	11
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program	11
An investigation of fentanyl and methamphetamine use among first-time arrestees from 25 county jails across the U.S. in 2023	10
A systematic review of substance use screening in outpatient behavioral health settings	10
Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries	9
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants	9
Methadone clinic staff perceptions of trauma-informed and patient-centered care: the role of individual staff characteristics	9
Patient experiences of buprenorphine dispensing from a mobile medical unit	9
Chronic unilateral groin pain in a young patient who injects drugs: a case report of needle fragment retentions	9
Substance use disorder bridge clinics: models, evidence, and future directions	9
“It beats the hell out of going to a hospital”: service user experiences of telemedicine-based symptom-triggered alcohol withdrawal management	9
Automated Reinforcement Management System (ARMS): focused phase I provider feedback	9
Patient characteristics associated with their level of twelve-step attendance prior to entry into treatment for substance use disorders	9
The development and initial validation of the Russian version of the BASIS-24	8
Developing practical strategies to reduce addiction-related stigma and discrimination in public addiction treatment centers: a mixed-methods study protocol	8
Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder	8
The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis	8
Rethinking trazodone for insomnia in alcohol use disorder	8
Rural and urban differences in undersupply of buprenorphine provider availability in the United States, 2018	8
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods	8
A protocol for a randomized comparison of extended-release versus sublingual buprenorphine among pre-trial detainees in jail	8
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule	8
Exemplar Hospital initiation trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098B a randomized implementation study to support hospitals in caring for patients with opioid use d	8
Effectiveness and feasibility of a motivational interviewing intake (MII) intervention for increasing client engagement in outpatient addiction treatment: an effectiveness-implementation hybrid design	7
Subtypes and service utilization among opioid use disorder patients at a community health center: findings from a medically underserved urban area of the Northeastern United States	7
Attitudes and training related to substance use in pediatric emergency departments	7
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology	7
Availability of medications for opioid use disorder in outpatient and inpatient pharmacies in South Florida: a secret shopper survey	7
Using mixed methods to establish tobacco treatment acceptability from the perspective of clients and clinicians of antenatal substance use services	7
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 rec	7
Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative	7
Rural providers’ attitudes toward integrating harm reduction strategies and PrEP prescribing into rural primary care settings in the US. Southeast and Midwest	7
The Spanish language version of the TAPS tool: protocol for a validation and implementation study in primary care	7
Organizational perspectives on the impacts of scaling up overdose education and naloxone distribution in Kentucky	7
Comparison of heroin and fentanyl use in US nationally representative surveys	7
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder	7
Proceedings of the 17th Annual International INEBRIA Conference	7

Toward Safer Opioid Prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial	7
Initiating buprenorphine to treat opioid use disorder without prerequisite withdrawal: an updated systematic review	6
The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography	6
Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities	6
Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study	6
“We need all hands on deck”: characterizing addiction medicine training in Canada—a mixed methods study of fellowship program directors	6
Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single	6
Improving alcohol health literacy and reducing alcohol consumption: recommendations for Germany	6
Training health professionals to reduce overreporting of birthing people who use drugs to child welfare	6
The associations between public stigma and support for others’ help-seeking for alcohol use disorder: a cross sectional study in the general Danish population	6
CTN-0138: adaptation, implementation, and cluster randomized trial of a Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool—a protocol paper	6
Coping motives mediate the relationship between PTSD and MDMA use in adolescents with substance use disorders	6
Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTRE): protocol for CTN-0098 an open-label randomized comparative effectiveness trial of extended-release buprenorphine versu	6
Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates	6
Perspectives of healthcare workers on the integration of overdose detection technologies in acute care settings	5
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial	5
Grayken Lessons: a patient who developed opioid use disorder after traumatic brain injury	5
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol	5
“Just fighting for my life to stay alive”: a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories	5
Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications and CBT4CBT: protocol for a randomized clinical trial in a diverse patient population	5
Study design to evaluate a web-intervention to prevent alcohol and cannabis-impaired driving and use among adolescents in driver education	5
Ketamine-assisted buprenorphine initiation: a pilot case series	5
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway	5
Prevalence and predictors of suicidality among adults initiating office-based buprenorphine	5
Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial	5
“It’s all about asking from those who have walked the path”: Patient and stakeholder perspectives on how peers may shift substance use stigma in HIV care in South Africa	5
PrEP facilitators and barriers in substance use bridge clinics for women who engage in sex work and who use drugs	5
Support after return to alcohol use: a mixed-methods study on how abstinence motivation and app use change after return to alcohol use in an app-based aftercare intervention for individuals with alcoh	5
Factors associated with patient-reported experiences and outcomes of substance use disorder treatment in Cape Town, South Africa	5
Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans	4
Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study	4
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services	4
Universal substance use care for adolescents with chronic medical conditions: a protocol to examine equitable implementation determinants and strategies for SBIRT at a pediatric hospital	4
Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum—20 years of research informing practice	4
The Functional-Cognitive and Sensory Treatment (F-CaST) to improve rehabilitation outcomes of individuals with substance use disorder: a study protocol for a mixed-method randomized controlled trial	4
Alcohol reduction strategies among persons with HIV: past attempts, self-reported effectiveness, and future strategies of interest	4
Strategies for improving treatment retention for buprenorphine/naloxone for opioid use disorder: a qualitative study of issues and recommendations from prescribers	4
Expanding access to medications for opioid use disorder through locally-initiated implementation	4
Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	4
Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities—overview and commentary	4
Perceptions of family physicians in Istanbul about e-cigarettes as smoking cessation aids: a qualitative study	4
Comparing cognitive behavioral therapy and social prescribing in patients with loneliness on long-term opioid therapy to reduce opioid misuse: protocol for a randomized controlled trial	4
Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care	4
Supporting primary care clinicians in caring for patients with alcohol use disorder: study protocol for Records for Alcohol Care Enhancement (RACE), a factorial four-arm randomized trial	4
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems	4
Confidence in providing methadone maintenance treatment of primary care providers in Vietnam	3
Case report: acute care management of severe opioid withdrawal with IV fentanyl	3
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help?	3
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis	3
Regaining control over alcohol intake but not abstinence on disulfiram medication, as a harm reduction approach: 2 case reports	3
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy	3
A case of severe opioid and methamphetamine use disorder in a 14 year old	3
Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis	3
Usability and cultural adaptation of a text message-based tobacco cessation intervention for people living with HIV in Uganda and Zambia	3
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder	3
Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model	3
Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder	3
Study protocol for a pilot randomized controlled trial to increase COVID-19 testing and vaccination among people who inject drugs in San Diego County	3
Substance use disorder and alcohol consumption patterns among Dutch physicians: a nationwide register-based study	3
Preoperative evaluation of alcohol consumption in older patients	3
Feasibility and acceptability of electronic administration of patient reported outcomes using mHealth platform in emergency department patients with non-medical opioid use	3
Exploring perceptions of genetic risk and the transmission of substance use disorders	3
“There’s a lot of people who love them, so why call ‘em junkies?”: clinician and patient perspectives about words used to describe people who use drugs	3
Optimizing tobacco treatment delivery for people with HIV: trial protocol for a randomized controlled trial	3
Provider perceptions of young people living with HIV and unhealthy alcohol use in Southwestern Uganda: a qualitative study	3
Organization of primary care and early MOUD discontinuation	3
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis	3
A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the “Break Free” program	3
‘The Drug Survey App’: a protocol for developing and validating an interactive population survey tool for drug use among Aboriginal and Torres Strait Islander Australians	3
GHB: a life-threatening drug complications and outcome of GHB detoxification treatment—an observational clinical study	3
Connect To Care (C2C): protocol for two-site randomized controlled pilot trial to improve outcomes for patients with hazardous drinking and PTSD and/or depression symptoms	3
The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-di	3
Reasons for not seeking alcohol treatment among a sample of Florida adults with HIV who perceived the need for treatment	3
Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey	2
Survey of Massachusetts peer recovery coaches’ attitudes toward the use of psychedelics to treat substance use disorders	2
Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial	2
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report	2
“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke	2
Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016–2018	2
Combining app-based behavioral therapy with electronic cigarettes for smoking cessation: a study protocol for a single-arm mixed-methods pilot trial	2

A personalized biomedical risk assessment infographic for people who smoke with COPD: a qualitative study	2
Barriers and facilitators of opioid treatment among Indigenous Syringe Services Program clients	2
Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis	2
Normalizing fentanyl: interpreting the perceived ‘risk’ of correctional officer work	2
Identifying unique barriers to implementing rural emergency department-based peer services for opioid use disorder through qualitative comparison with urban sites	2
Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis	2
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes	2
Provider perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment	2
Implementing a pharmacist-integrated collaborative model of medication treatment for opioid use disorder in primary care: study design and methodological considerations	2
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder	2
Repetitive transcranial magnetic stimulation for stimulant use disorders (STIMULUS): protocol for a multi-site, double-blind, randomized controlled trial	2
HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England	2
Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study	2
Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project	2
Acceptability of “DIDE”, a mobile application designed at facilitating care adherence of patients with substance use disorder	2
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review	2
Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review	2
Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder	2
Prevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy	2
Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report	2
Augmenting project ECHO for opioid use disorder with data-informed quality improvement	2
Attachment styles and sense of coherence as indicators of treatment adherence and completion among individuals with substance use disorder	2
How emergency departments are responding to the opioid crisis: Results from a statewide survey in Kentucky	2
“Ignite & engage:” A mixed methods evaluation of a peer-led, school-based substance use prevention program	2
Correction: Do in-person and computer-based brief alcohol interventions reduce tobacco smoking among general hospital patients? Secondary outcomes from a randomized controlled trial	2
Psychometric properties of Fagerström Tolerance Questionnaire among Turkmen Nass (Naswar) users	2
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study	2
A qualitative interview study of patient experiences of receiving motivational enhancement therapy in a Swedish addiction specialist treatment setting	2
Correction: Pilot testing a novel remotely delivered intensive outpatient program for hospitalized patients with opioid use disorder	2
Inpatient detoxification for alcohol and other drug use: qualitative study of patients’ accounts of their relationships with staff	2
Using intervention mapping for hookah smoking cessation: a quasi-experimental evaluation	2
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study	2
The identification and treatment of alcohol problems in primary care (iTAPP) study: protocol for a stepped wedge cluster randomized control trial testing the 15-method in a primary care setting	2
A novel online vaping intervention and smoking prevention program for young adults who vape: protocol for a randomized controlled trial	2
Exploring barriers and facilitators to addressing hazardous alcohol use and AUD in mental health services: a qualitative study among Dutch professionals	2
Inpatient addiction care is associated with increased vaccinations, medication for opioid use disorder and naloxone prescribing among patients with infective endocarditis in a rural state	2
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities	2
Feasibility of precision smoking treatment in a low-income community setting: results of a pilot randomized controlled trial in The Southern Community Cohort Study	2